Background New drug treatments, clinical trials, and standards of quality for assessment of
evidence justify an update of evidence-based recommendations for the pharmacological …

Adaptive heterothermy and selective brain cooling are regarded as important thermal
adaptations of large arid-zone mammals. Adaptive heterothermy, a process which reduces …

Multiple recent pharmacological clinical trials in neuropathic pain have failed to show
beneficial effect of drugs with previously demonstrated efficacy, and estimates of drug efficacy …

HIV‐associated sensory neuropathy (HIV‐SN) is a frequent neurological complication of HIV
infection and its treatment with some antiretroviral drugs. We review the pathogenesis of the …

CONTEXT: HIV-associated sensory neuropathy (HIV-SN) is a frequent complication of both
HIV and neurotoxic antiretroviral medications such as stavudine. OBJECTIVE: To determine …

For genetic research to contribute more fully to furthering our knowledge of neuropathic pain,
we require an agreed, valid, and feasible approach to phenotyping, to allow collaboration …

HIV-associated sensory neuropathy (HIV-SN) remains a common neurological complication
of HIV infection despite the introduction of effective antiretroviral therapies. Exposure to …

Limited information on the prevalence and risk factors for chronic pain is available for
developing countries. Therefore, we investigated the prevalence of chronic pain and the …

Neuropathic pain has been deemed a priority health issue5 and is the topic of the 2014 to
2015 Global Year Against Neuropathic Pain campaign of the International Association for the …

HIV-associated sensory peripheral neuropathy (HIV-SN) afflicts approximately 50% of
patients on antiretroviral therapy, and is associated with significant neuropathic pain. Simple …